MHRA

CASGEVY | 1st Gene-Editing Therapy for Thalassaemia and SCD Approved in UK

Casgevy is the first medicine to be licensed that uses the innovative gene-editing tool CRISPR, for which its inventors were awarded the Nobel Prize in 2020. The therapy, developed by…